Analyst Actions -- 11/2/2011

 | Nov 02, 2011 | 8:30 AM EDT  | Comments
  • Comment
  • Print Print
  • Print
Stock quotes in this article:

open

,

de

,

cme

,

cat

,

adm

,

bhi

,

thc

,

hca

,

anf

,

glw

,

ua

,

nke

Abercrombie & Fitch cut from Conviction Buy List at Goldman

ANF was removed from the Conviction Buy list, Goldman Sachs said. Valuation call, as the stock is up 32% over the past 11 months.

-----

Aeropostale upgraded at Goldman

ARO was upgraded from Sell to Neutral, Goldman Sachs said. The company can expand margins in the coming quarter.

-----

American Tower numbers adjusted at Citigroup

Shares of AMT now seen reaching $65, according to Citigroup.  Estimates lowered on FX headwinds.  Buy rating.

-----

American Tower estimates, target raised at JP Morgan

Shares of AMT now seen reaching $62, according to JP Morgan.  Estimates also increased on Core and Sprint MLA.

-----

AmerisourceBergen estimates increased at UBS

ABC estimates increased through 2013, UBS said.  Positive operating trends.  Maintain $47 price target and Buy rating. 

-----

Ann downgraded at Goldman

ANN was downgraded from Neutral to Sell, Goldman Sachs said. Margins are peaking and the company is leveraged to slower macro growth.

-----

Archer Daniels Midland numbers cut at Morgan Stanley

Shares of ADM now seen reaching $37, according to Morgan Stanley. Estimates also reduced, given lower oilseed margins. Overweight rating.

-----

Atmel downgraded at Needham

ATML was downgraded from Strong Buy to Buy, Needham said. Company could face inventory rebalancing in the next couple of quarters.

-----

Autodesk target cut at UBS

ADSK target lowered to $43, UBS said.  VARs continue to plod through a sluggish economic environment.  Buy rating.

-----

Baker Hughes numbers cut at Credit Suisse

Shares of BHI now seen reaching $80, according to Credit Suisse. Estimates also reduced, given lower expected North American pricing. Outperform rating.

-----

Baker Hughes estimates increased at Sterne Agee

BHI estimates raised through 2012, Sterne Agee said.  Bullish rig count forecast.  Maintain $71 price target and Buy rating. 

-----

Baker Hughes estimates, target cut at UBS

Shares of BHI now seen reaching $82, according to UBS.  Estimates also increased as overall story is still in on track despite a sloppy 3Q.  Buy rating. 

-----

Catalyst Health numbers lowered at Credit Suisse

Shares of CHSI now seen reaching $62, according to Credit Suisse. Estimates also cut, to match the company's new guidance. Outperform rating.

-----

Caterpillar rated new Overweight at Morgan Stanley

CAT was initiated with an Overweight rating, Morgan Stanley said. Valuation call, based on a $125 price target.

-----

CME Group numbers lowered at Jefferies

CME estimates were cut through 2012, Jefferies said. Volume has moderates and expenses could be back on the rise. Buy rating and new $297 price target.

-----

CME Group estimates lowered at UBS

CME estimates lowered through 2012, UBS said.  MF Global bankruptcy may be a blow to the futures industry as a whole.  Buy rating. 

-----

Corning downgraded at JP Morgan

GLW was downgraded from Neutral to Underweight, JP Morgan said. Consumer risks are mounting.

-----

Deere rated new Underweight at Morgan Stanley

Coverage of DE was started with an Underweight rating, Morgan Stanley said. Company faces slower growth and margin pressures. $74 price target.

-----

Diamond Foods downgraded at BofA/Merrill

DMND was downgraded from Buy to Neutral, Bank of America/Merrill Lynch said. $65 price target. Estimates also cut, as the Pringles acquisition has been delayed.

-----

Discovery Communications numbers increased at UBS

Shares of DISCA now seen reaching $43, according to UBS.  Estimates also raised as Netflix deal more accretive than expectations.  Neutral rating.

-----

Emerson Electric target increased at UBS

EMR target increased to $51, UBS said.  Positive outlook despite challenging macro.  Maintain Neutral rating.

-----

Emerson Electric estimates, target cut at Sterne Agee

Shares of EMR now seen reaching $54, according to Sterne Agee.  Estimates also lowered on slower expected global growth.  Neutral rating. 

-----

EOG Resources estimates increased at UBS

EOG estimates increased through 2012, UBS said.  3Q beats on higher than expected natural gas and NGL production.  Neutral rating.  

-----

Fidelity estimates, target lowered at Oppenheimer

FIS estimates were cut through 2012, Oppenheimer said. EBITDA growth is slowing. Outperform rating and new $32 price target.

-----

FXCM upgraded at Citigroup

FXCM was upgraded from Sell to Neutral, Citigroup said.  $11.25 price target.  With the recent downdraft we see a more balanced risk/reward.

-----

HCA estimates, target raised at Credit Suisse

Shares of HCA now seen reaching $27, according to Credit Suisse. Estimates also increased, given solid volume growth and cost cuts. Outperform rating.  

-----

Impax Laboratories numbers cut at Goldman

Shares of IPXL now seen reaching $18, according to Goldman Sachs. Estimates also reduced, given lower expected Adderall XR sales. Sell rating.

-----

Intrepid Potash rated new Neutral at UBS

IPI was initiated with a Neutral rating, UBS said.  $28 price target.  Significant growth, but at a fair price. 

-----

IPG Photonics upgraded at Needham

IPGP was upgraded from Hold to Buy, Needham said. $60 price target. Company has solid visibility.

-----

Lamar Advertising numbers cut at Benchmark

Shares of LAMR now seen reaching $18, according to Benchmark. Estimates also reduced, as the outdoor advertising market has stalled. Hold rating.

-----

MEMC Electronic Materials numbers lowered at Citigroup

Shares of WFR now seen reaching $10, according to Citigroup.  Estimates also lowered on softer wafer volumes/pricing.  Buy rating.

-----

MetroPCS Communications estimates lowered at Citigroup

PCS estimates lowered through 2012, Citigroup said.  Smartphone strategy may be misaligned with its historical success as a low cost provider.  Neutral rating.

-----

MetroPCS upgraded at JP Morgan

PCS was upgraded from Neutral to Overweight, JP Morgan said.  Better than expected 3Q11 subscriber performance which sets a base line for the business in its typically weakest quarter. 

-----

Monsanto rated new Neutral at UBS

MON was initiated with a Neutral rating, UBS said.  $72 price target.  Stock valuation stretched to the limit. 

-----

Myriad Genetics upgraded at Ticonderoga

MYGN was upgraded from Neutral to Buy, Ticonderoga said. $25 price target. BRAC Analysis continues to perform well.

-----

NII Holdings estimates, target cut at Citigroup

Shares of NIHD now seen reaching $45, according to Citigroup.  Estimates also lowered on 3G opex costs.  Buy rating.

-----

Nike upgraded at Goldman

NKE was upgraded from Neutral to Buy, Goldman Sachs said. Company was also added to the Conviction List. Stock usually performs well in an Olympic year.

-----

OpenTable downgraded at BofA/Merrill

OPEN was downgraded from Buy to Neutral, Bank of America/Merrill Lynch said. Valuation call, based on a $48 price target.

-----

OpenTable downgraded at Morgan Keegan

OPEN was downgraded from Outperform to Market Perform, Morgan Keegan aid. $39 price target. Slower macro growth could weigh on earnings.

-----

OpenTable estimates, target cut at Citigroup

Shares of OPEN now seen reaching $67, according to Citigroup.  Estimates also lowered on removal of spotlight revenue and restaurant industry macro weakness.  Buy rating.

-----

OpenTable estimates, target reduced at Oppenheimer

Shares of OPEN now seen reaching $54, according to Oppenheimer. Estimates also cut, given slower realized growth. Outperform rating.

-----

Oshkosh Truck upgraded at Benchmark

OSK was upgraded from Hold to Sell, Benchmark said. $20 price target. Consensus expectations have come down to a reasonable level.

-----

Oshkosh downgraded at Sterne Agee

OSK was downgraded from Neutral to Underperform, Sterne Agee said. $16 price target. Defense business remains weak and it will likely be another year of transition for the commercial division.

-----

Pinnacle West estimates increased at UBS

PNW estimates increased through 2011, UBS said.  AZ Sun plan continues to gain traction.  Maintain $45 price target and Neutral rating.

-----

Praxair downgraded at Argus

PX was downgraded from Buy to Hold, Argus Research said. Valuation call.

-----

Ritchie Bros. upgraded at Baird

RBA was upgraded from Neutral to Outperform, Robert Baird said. $25 price target. Earnings should bounce back in the fourth quarter, due to a calendar shift.

----

Rowan estimates, target reduced at Jefferies

RDC estimates were cut through 2012, Jefferies said. Company is facing higher costs. Buy rating and new $48 price target.

-----

SM Energy numbers cut at Jefferies

Shares of SM now seen reaching $110, according to Jefferies. Estimates also reduced, as growth is slowing outside of Eagle Ford. Buy rating.

-----

Tenet Healthcare numbers boosted at Credit Suisse

Shares of THC now seen reaching $6, according to Credit Suisse. Estimates also upped, given higher expected near-term growth. Outperform rating.

-----

Texas Roadhouse downgraded at Credit Suisse

TXRH was downgraded from Outperform to Neutral, Credit Suisse said. $16.50 price target. Company has limited pricing power.

-----

Thoratec estimates increased at UBS

THOR estimates lowered through 2012, UBS said.  Guidance elevated on margins.  Maintain $39 price target and Buy rating. 

-----

Treehouse Foods downgraded at Wells

THS was downgraded from Outperform to Market Perform, Wells Fargo said. Valuation call.

-----

Triumph estimates, target raised at Credit Suisse

Shares of TGI now seen reaching $68, according to Credit Suisse. Estimates also increased, as the company remains leveraged to the aerospace cycle. Outperform rating.

-----

Under Armour upgraded at Goldman

UAUA was upgraded from Neutral to Buy, Goldman Sachs said. Brand momentum can help drive margin growth.

-----

US Cellular downgraded at Morgan Stanley

USM was downgraded from Equal-weight to Underweight, Morgan Stanley said. $35 price target. Company is facing increased competition.

-----

Westlake Chemical estimates cut at UBS

WLK estimates lowered through 2012, UBS said.  Margin squeeze on polyolefins.  Maintain $45 price target and Neutral rating.

Columnist Conversations

Detected from Trade Alert: Active trading in GOGO. The stock hit a high of $18.07 and is up 4.6% to $17.56 on ...
August 18: BEN actually traded a little lower after my August 1 column. On August 6 BEN had a reversal day and...
EBAY sees heavy trading. The stock is up 5% to $56.10 and moving to session highs on increasing volume of 17 m...
I was recently looking into GOGO as a potential growth stock investment, but dropped it after deciding the val...

BEST IDEAS

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.